<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sahin SI</submitter><funding>NIH HHS</funding><pagination>736-749</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10143874</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(2)</volume><pubmed_abstract>Metabolite-specific echo-planar imaging (EPI) sequences with spectral-spatial (spsp) excitation are commonly used in clinical hyperpolarized [1-&lt;sup>13&lt;/sup>C]pyruvate studies because of their speed, efficiency, and flexibility. In contrast, preclinical systems typically rely on slower spectroscopic methods, such as chemical shift imaging (CSI). In this study, a 2D spspEPI sequence was developed for use on a preclinical 3T Bruker system and tested on in vivo mice experiments with patient-derived xenograft renal cell carcinoma (RCC) or prostate cancer tissues implanted in the kidney or liver. Compared to spspEPI sequences, CSI were found to have a broader point spread function via simulations and exhibited signal bleeding between vasculature and tumors in vivo. Parameters for the spspEPI se</pubmed_abstract><journal>Tomography (Ann Arbor, Mich.)</journal><pubmed_title>Metabolite-Specific Echo Planar Imaging for Preclinical Studies with Hyperpolarized &lt;sup>13&lt;/sup>C-Pyruvate MRI.</pubmed_title><pmcid>PMC10143874</pmcid><funding_grant_id>R01CA249909</funding_grant_id><funding_grant_id>P41EB013598</funding_grant_id><funding_grant_id>U24CA253377</funding_grant_id><pubmed_authors>Mattingly M</pubmed_authors><pubmed_authors>Sinha A</pubmed_authors><pubmed_authors>Gordon JW</pubmed_authors><pubmed_authors>Ji X</pubmed_authors><pubmed_authors>Mali I</pubmed_authors><pubmed_authors>Agarwal S</pubmed_authors><pubmed_authors>Sahin SI</pubmed_authors><pubmed_authors>Kurhanewicz J</pubmed_authors><pubmed_authors>Subramaniam S</pubmed_authors><pubmed_authors>Larson PEZ</pubmed_authors><pubmed_authors>Sriram R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Metabolite-Specific Echo Planar Imaging for Preclinical Studies with Hyperpolarized &lt;sup>13&lt;/sup>C-Pyruvate MRI.</name><description>Metabolite-specific echo-planar imaging (EPI) sequences with spectral-spatial (spsp) excitation are commonly used in clinical hyperpolarized [1-&lt;sup>13&lt;/sup>C]pyruvate studies because of their speed, efficiency, and flexibility. In contrast, preclinical systems typically rely on slower spectroscopic methods, such as chemical shift imaging (CSI). In this study, a 2D spspEPI sequence was developed for use on a preclinical 3T Bruker system and tested on in vivo mice experiments with patient-derived xenograft renal cell carcinoma (RCC) or prostate cancer tissues implanted in the kidney or liver. Compared to spspEPI sequences, CSI were found to have a broader point spread function via simulations and exhibited signal bleeding between vasculature and tumors in vivo. Parameters for the spspEPI se</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Mar</publication><modification>2025-04-18T16:29:57.604Z</modification><creation>2025-04-07T03:43:29.302Z</creation></dates><accession>S-EPMC10143874</accession><cross_references><pubmed>37104130</pubmed><doi>10.3390/tomography9020059</doi></cross_references></HashMap>